NYSE$KVUE

Kenvue Inc · Q1 2025 earnings

Q1 2025 earnings · · Before market open · Investor relations

Briefing

Kenvue reported Q1 2025 net sales of $3.74B with net income of $322M and diluted EPS of $0.17.

Net sales were $3.74 billion for the quarter ended March 30, 2025, down 3.9% year over year. Net income was $322 million; diluted EPS was $0.17. Self Care, Skin Health & Beauty, and Essential Health segments drove the mix.

  • Q1 net sales $3.74B (-3.9% YoY).
  • Net income $322M; diluted EPS $0.17.
  • Iconic OTC brands support cash generation.
  • Category softness and FX weigh on top-line growth.

Headline financials

Total Revenue

$3.74B

Previous: $3.89B-3.9%
EPS (adj)

$0.17

Previous: $0.28-39.3%
Gross Profit Margin

58.0%

No prior period
Adjusted Gross Margin

60.0%

No prior period
Operating Margin

14.9%

No prior period
Adjusted Operating Margin

19.8%

No prior period
Effective Tax Rate

29.7%

No prior period
Adjusted Tax Rate

27.5%

No prior period
R&D Expenses

$99M

No prior period
Organic Sales Growth

-1.2%

No prior period
Organic Volume Growth

-0.9%

No prior period
Organic Price/Mix Growth

-0.3%

No prior period
Capital Expenditures

-$200M

Previous: -$153M-30.7%
Net Income

$322M

Previous: $296M+8.8%
Operating Income

$558M

Previous: $550M+1.5%
Gross Profit

$2.17B

Previous: $2.24B-3.3%

Revenue & EPS history

Kenvue · Revenue · Quarterly

$3.74B

Q1 2025-3.9%vs Q1 2024
Beat estimate in 7 of 12 quarters(58%)
ActualEstimate

Revenue by segment

Kenvue · $3.92B total across 3 segments · Q3 2023

  • Self Care
    $1.61B+6.4%
  • Essential Health
    $1.18B+3.0%
  • Skin Health & Beauty
    $1.12B-0.4%

Forward guidance

Consumer and beverage outlook depends on pricing, volumes, and promotional activity.

Tailwinds

  • Brand strength and innovation pipeline.
  • Cost productivity and mix improvements.

Headwinds

  • Input inflation and private-label competition.
  • Retail inventory and macro discretionary trends.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 13 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+2.0%

Avg return

Earnings day

+3.1%

Avg return

5 days after

+2.8%

Avg return

30 days after

57%

8 / 14 earnings

Positive

+15.7%

Q3 2025

Best reaction

-7.7%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.0%-1.2%+0.2%
Q4 2025+0.9%+2.9%-5.5%
Q3 2025+15.7%+17.5%+18.1%
Q2 2025+1.5%+2.1%-13.2%
Q1 2025+4.3%+2.4%-6.0%
Q4 2024-4.5%+0.8%+12.9%
Q3 2024+5.2%+5.1%+1.5%
Q2 2024+13.4%+15.6%+23.7%
Q1 2024+7.2%+7.7%-2.4%
Q4 2022-0.2%+3.1%+12.9%
Q4 2023-5.8%-6.2%-2.4%
Q3 2023-7.7%-5.7%+2.6%
Q2 2023-4.0%+0.5%-8.5%
Q1 2023-0.5%-0.8%+4.5%
Q3 2022
Q2 2022
Q1 2022
Q4 2021

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro